Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Adverse Effects of Niraparib in Ovarian Cancer: a Prospective Real-world Product Registration Study.

NCT05583799 is registered in ClinicalTrials.gov with First Affiliated Hospital Xi'an Jiaotong University as lead sponsor.

NCT NCT05583799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05583799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Adverse Effects of Niraparib in Ovarian Cancer: a Prospective Real-world Product Registration Study.
Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University
Phase
Observational
Overall status
Unknown status
Start date
October 15, 2022
Completion date
September 30, 2025
Enrollment
222 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer